Compare ADMA Biologics Inc (ADMA) vs First Citizens BancShares Inc (FCNCA) Price & Performance

ADMA Biologics IncTrade

First Citizens BancShares IncTrade

Price performance (Past 24H)

Key statistics

ADMA Biologics Inc vs First Citizens BancShares Inc — how do they compare? ADMA Biologics Inc trades at $9.35 (market cap $2.19B), while First Citizens BancShares Inc trades at $2,270.44 (market cap $25.26B). The key difference: First Citizens BancShares Inc is far larger — about 11.5× ADMA Biologics Inc's market cap, and First Citizens BancShares Inc pays a 0.37% dividend while ADMA Biologics Inc pays none. Which is the better fit depends on your goals.

	ADMA	FCNCA
Market Cap	$2.19B	$25.26B
Sector	Health	Sector/Thematic
52-Week High	$20.38	$2.27K
52-Week Low	$7.60	$1.64K
Enterprise Value	$2.26B	—
Dividend Yield	—	0.37%

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

ADMA

ADMA Biologics sees 24% ASCENIV revenue growth in Q2 despite lowered long-term targetsSeeking Alpha · 1 day agoBullish Investigation launched into ADMA Biologics for alleged channel-stuffing to boost ASCENIV sales.Newsfile Corp · 1 day agoBearish View details →

FCNCA

Revman International secures $87M financing from First Citizens Bank for expansion.PRNewsWire · 1 day agoBullish View details →

About ADMA Biologics Inc

ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.

About First Citizens BancShares Inc

First Citizens BancShares is a major US regional bank providing diverse financial services. It recently expanded significantly by acquiring the assets and liabilities of Silicon Valley Bank.